FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

MRI-guided radiation therapy improves quality of life with fewer side effects in patients with localized cancer. JAMA

2.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

3.

NEJM: Fluorescent guide can aid in the detection of tumors that are still present after breast cancer surgery.

4.

High Rate of Deep Remission for Relapsed/Refractory CLL Using Triple Regimen.

5.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot